scholarly journals Post-slaughter changes in rabbit carcasses in Poland between 2010 and 2018

2019 ◽  
Vol 75 (10) ◽  
pp. 6294-2019
Author(s):  
ŁUKASZ DROZD ◽  
WALDEMAR PASZKIEWICZ ◽  
RENATA PYZ-ŁUKASIK ◽  
MONIKA ZIOMEK ◽  
KRZYSZTOF SZKUCIK
Keyword(s):  
Infectious Diseases ◽  
Respiratory Tract ◽  
Fold Increase ◽  
Parasitic Diseases ◽  
Upper Respiratory Tract ◽  
Pathological Changes ◽  
Respiratory Tract Disease ◽  
Internal Organs ◽  
Upper Respiratory ◽  
Tract Disease

The aim of the study was to analyze the results of sanitary and veterinary examinations of rabbits carried out by the Veterinary Inspectorate in slaughterhouses in Poland in 2010-2018. In this period, 8,980,660 rabbits were examined. Lesions and quality deviations were found in 42,779 carcasses, i.e. 0.48% of all carcasses examined. The most frequent causes of the rejection of the carcasses and internal organs of the rabbits examined were sepsis and pyaemia (36,369 cases), followed by excessive emaciation (1,686 cases), upper respiratory tract disease (1,655 cases), other causes not specified by name (1,438 cases), and coccidiosis (1,318 cases). Abnormal exsanguination (303), parasitic diseases other than coccidiosis (67), infectious diseases (14), and leukemia (2) were much less often the cause of rejection. During the period analyzed, there was a decrease in the number of cases of coccidiosis (except in 2017) and other parasitic diseases, but there was a several-fold increase in the occurrence of sepsis and pyaemia (in the years 2015-2018). Compared with the results of veterinary and sanitary examinations of rabbits in 2000-2010, there was an increase in the number of rabbits slaughtered and a reduction in the percentage of carcasses with pathological changes and carcasses deemed unfit for consumption. In the years 2010-2018, there was also an increase in the number of cases of sepsis and pyaemia and a significant decrease in the percentage of parasitic diseases (mainly coccidiosis).

Diagnostic Techniques in Equine Upper Respiratory Tract Disease

2012 ◽  
pp. 536-557 ◽  
Author(s):  
Eric J. Parente ◽  
Samantha H. Franklin ◽  
Frederik J. Derksen ◽  
Michael A. Weishaupt ◽  
Heather J. Chalmers ◽  
...  
Keyword(s):  
Respiratory Tract ◽  
Diagnostic Techniques ◽  
Upper Respiratory Tract ◽  
Respiratory Tract Disease ◽  
Upper Respiratory ◽  
Upper Respiratory Tract Disease ◽  
Tract Disease

scholarly journals Effects of famciclovir in cats with spontaneous acute upper respiratory tract disease

2019 ◽  
Vol 22 (6) ◽  
pp. 492-499
Author(s):  
Lucy Kopecny ◽  
David J Maggs ◽  
Christian M Leutenegger ◽  
Lynelle R Johnson
Keyword(s):  
Respiratory Tract ◽  
Clinical Signs ◽  
Response To Therapy ◽  
Study Entry ◽  
Upper Respiratory Tract ◽  
Respiratory Tract Disease ◽  
Upper Respiratory ◽  
Upper Respiratory Tract Disease ◽  
Tract Disease ◽  
Group D

Objectives The aim of this study was to assess the effects of famciclovir administration in cats with spontaneously acquired acute upper respiratory tract disease. Methods Twenty-four kittens with clinical signs of acute upper respiratory tract disease were randomly allocated to receive doxycycline (5 mg/kg PO q12h) alone (group D; n = 12) or with famciclovir (90 mg/kg PO q12h; group DF; n = 12) for up to 3 weeks. Clinical disease severity was scored at study entry and daily thereafter. Oculo-oropharyngeal swabs collected at study entry and exit were assessed using quantitative PCR for nucleic acids of feline herpesvirus type 1 (FHV-1), feline calicivirus (FCV), Chlamydia felis, Bordetella bronchiseptica and Mycoplasma felis. Results The median (range) age of cats was 1.5 (1–6) months in group D vs 1.6 (1–5) months in group DF ( P = 0.54). Pathogens detected in oculo-oropharyngeal swabs at study entry included FCV (n = 13/24; 54%), M felis (n = 8/24; 33%), FHV-1 (n = 7/24; 29 %), C felis (n = 7/24; 29%) and B bronchiseptica (n = 3/24; 12%). Median (range) duration of clinical signs was 11.5 (3–21) days in group DF and 11 (3–21) days in group D ( P = 0.75). Median (range) total disease score at the end of the study did not differ between groups (group D 1 [1–1] vs group DF 1 [1–3]; P = 0.08). Conclusions and relevance This study revealed no significant difference in response to therapy between cats treated with doxycycline alone or with famciclovir; cats improved rapidly in both groups. However, identification of FHV-1 DNA was relatively uncommon in this study and clinical trials focused on FHV-1-infected cats are warranted to better evaluate famciclovir efficacy.

Sign in / Sign up

Export Citation Format

Share Document